Advertisement

Topics

Invacare Corporation Appoints Petra Danielsohn-Weil, PhD, to Board of Directors

16:51 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Invacare Corporation (NYSE: IVC) today announced the appointment of Petra Danielsohn-Weil, PhD, to its Board of Directors, effective May 17, 2018. From 2014 until her retirement in August 2017, Ms. Danielsohn-Weil was the Region...

Other Sources for this Article

Invacare Corporation
Lois Lee, 440-329-6435
loislee@invacare.com

NEXT ARTICLE

More From BioPortfolio on "Invacare Corporation Appoints Petra Danielsohn-Weil, PhD, to Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...